IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: Synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5455-5465

  Yamaguchi, Masao ^a,d   Sayama, Koichi ^a   Yano, Koji ^a,e   Lantz, Chris S ^a   Noben Trauth, Nancy ^b   Ra, Chisei ^c   Costa, John J ^a   Galli, Stephen J ^a,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JUNTENDO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NAGASAKI UNIVERSITY   (Japan)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; LEUKOTRIENE C4; PROSTAGLANDIN D2;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CELL DIFFERENTIATION; CELL MEMBRANE; DRUG COMBINATIONS; DRUG SYNERGISM; FETAL BLOOD; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; LIPID METABOLISM; LIPIDS; MAST CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, IGE; UMBILICAL VEINS; UP-REGULATION;

EID: 0033136727     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ishizaka, T., and K. Ishizaka. 1984. Activation of mast cells for mediator release through IgE receptors. Prog. Allergy 34:188.
2. Bochner, B. S., and L. M. Lichtenstein. 1991. Anaphylaxis. N. Engl. J. Med. 324:1785.
3. Ravetch, J. V., and J.-P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457.
4. Beaven, M. A., and H. Metzger. 1993. Signal transduction by Fc receptors: the Fc∈RI case. Immunol. Today 14:222.
5. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328:257.
6. + cells. Adv. Immunol. 53:1.
7. Saxon, A., D. Diaz-Sanchez, and K. Zhang. 1996. The allergic response in host defense. In Clinical Immunology: Principles and Practice, Vol. 1. R. R. Rich, T. A. Fleisher, B. D. Schwartz, W. T. Shearer, and W. Strober, eds. Mosby-Year Book, St. Louis, p. 847.
8. Dombrowicz, D., V. Flamand, K. K. Brigman, B. H. Koller, and J.-P. Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 75:969.
9. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR γ chain deletion results in pleiotropic effector cell defects. Cell 76:519.
10. Ownby, D. R. 1993. Clinical significance of IgE. In Allergy. Principles and Practice, Vol. I, 4th Ed. E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., J. W. Yunginger, and W. W. Busse, eds. Mosby-Year Book, St. Louis, p. 1059.
11. Conroy, M. C., N. F. Adkinson, Jr., and L. M. Lichtenstein. 1977. Measurements of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J. Immunol. 118:1317.
12. Stallman, P. J., R. C. Aalberse, P. C. Bruhl, and E. H. Van Elven. 1977. Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy. Int. Arch. Allergy Appl. Immunol. 54:364.
13. Yamaguchi, M., C. S. Lantz, H. C. Oettgen, I. M. Katona, T. Fleming, I. Miyajima, J.-P. Kinet, and S. J. Galli. 1997. IgE enhances mouse mast cell Fc∈RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 185:663.
14. Hsu, C., and D. MacGlashan, Jr. 1996. IgE antibody up-regulates high affinity IgE binding on murine bone marrow derived mast cells. Immunol. Lett. 52:129.
15. Shaikh, N., J. Rivera, B. R. Hewlett, R. H. Stead, F.-G. Zhu, and J. S. Marshall. 1997. Mast cell Fc∈RI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE. J. Immunol. 158:3805.
16. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr., J. Holmes, J. Ohara, A. S. Tung, J. V. G. Sample, and W. E. Paul. 1988. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:2335.
17. Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
18. Yano, K., M. Yamaguchi, F. de Mora, C. S. Lantz, J. H. Butterfield, J. J. Costa, and S. J. Galli. 1997. Production of macrophage inflammatory protein-1α by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE binding ability. Lab. Invest. 77:185.
19. Kimata, H., A. Yoshida, C. Ishioka, M. Fujimoto, I. Lindley, and K. Furusho. 1996. RANTES and macrophage inflammatory protein 1α selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J. Exp. Med. 183:2397.
20. Toru, H., C. Ra, S. Nonoyama, K. Suzuki, J.-i. Yata, and T. Nakahata. 1996. Induction of the high-affinity IgE receptor (Fc∈RI) on human mast cells by IL-4. Int. Immunol. 8:1367.
21. Pawankar, R., M. Okuda, H. Yssel, K. Okumura, and C. Ra. 1997. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc∈RI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99:1492.
22. Xia, H.-Z., Z. Du, S. Craig, G. Klisch, N. Noben-Trauth, J. P. Kochan, T. H. Huff, A.-M. A. Irani, and L. B. Schwartz. 1997. Effect of recombinant human IL-4 on tryptase, chymase, and Fc∈ receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J. Immunol. 159:2911.
23. Yamaguchi, M., C. S. Lantz, H. C. Oettgen, I. M. Katona, T. Fleming, K. Yano, I. Miyajima, J.-P. Kinet, and S. J. Galli. 1997. IgE enhances mouse and human mast cell Fc∈RI expression, which in turn enhances IgE-dependent mast cell mediator release. J. Allergy Clin. Immunol. 99:S104.
24. 2 from cord blood mononuclear cells. J. Immunol. 157:343.
25. Costa, J. J., G. D. Demetri, T. J. Harrist, A. M. Dvorak, D. F. Hayes, E. A. Merica, D. M. Menchaca, A. J. Gringeri, L. B. Schwartz, and S. J. Galli. 1996. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J. Exp. Med. 183: 2681.
26. Kimura, I., Y. Moritani, and Y. Tanizaki. 1973. Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy 3:195.
27. Yanagihara, Y., K. Kajiwara, K. Ikizawa, T. Koshio, K. Okumura, and C. Ra. 1994. Recombinant soluble form of the human high-affinity immunoglobulin E (IgE) receptor inhibits IgE production through its specific binding to IgE-bearing B cells. J. Clin. Invest. 94:2162.
28. Noben-Trauth, N., P. Kropf, and I. Müller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987.
29. Ryan, J., L. McReynolds, C. Shelbume, G. Klisch, S. DeSimone, P. Mirmonsef, T. Huff, and R. Kovacs. 1998. IL-4 inhibits Fc∈RI expression on murine mast cells through a stat 6-dependent mechanism. FASEB J. 12:A1061 (Abstr.).
30. Banks, E. M. S., and J. W. Coleman. 1996. A comparative study of peritoneal mast cells from mutant IL-4 deficient and normal mice: evidence that IL-4 is not essential for mast cell development but enhances secretion via control of IgE binding and passive sensitization. Cytokine 8:190.
31. Toru, H., M. Eguchi, R. Matsumoto, M. Yanagida, J. Yata, and T. Nakahata. 1998. Interleukin-4 promotes the development of tryplase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91:187.
32. Coleman, J. W., M. R. Holliday, I. Kimber, K. M. Zsebo, and S. J. Galli. 1993. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J. Immunol. 150:556.
33. Egger, D., S. Geuenich, C. Denzlinger, E. Schmitt, R. Mailhammer, H. Ehrenreich, P. Dörmer, and L. Hültner. 1995. IL-4 renders mast cells functionally responsive to endothelin-1. J. Immunol. 154:1830.
34. MacGlashan, D. W. Jr., B. S. Bochner, D. C. Adelman, P. M. Jardieu, A. Togias, J. McKenzie-White, S. A. Sterbinsky, R. G. Hamilton, and L. M. Lichtenstein. 1997. Down-regulation of Fc∈RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 158:1438.
35. Lantz, C. S., M. Yamaguchi, H. C. Oettgen, I. M. Katona, I. Miyajima, J.-P. Kinet, and S. J. Galli. 1997. IgE regulates mouse basophil Fc∈RI expression in vivo. J. Immunol. 158:2517.
36. Wollenberg, A., S. Kraft, D. Hanau, and T. Bieber. 1996. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J. Invest. Dermatol. 106:446.
37. Maurer, D., E. Fiebiger, B. Reininger, B. Wolff-Winiski, M.-H. Jouvin, O. Kilgus, J.-P. Kinet, and G. Stingl. 1994. Expression of functional high affinity immunoglobulin E receptors (Fc∈RI) on monocytes of atopic individuals. J. Exp. Med. 179:745.
38. Gounni, A. S., B. Lamkhioued, K. Ochiai, Y. Tanaka, E. Delaporte, A. Capron, J.-P. Kinet, and M. Capron. 1994. High-affinity IgE receptor on eosinophils is involved in defense against parasites. Nature 367:183.
39. DeLisi, C., and R. P. Siraganian. 1979. Receptor cross-linking and histamine release: the quantitative dependence of basophil degranulation on the number of receptor doublets. J. Immunol. 122:2286.
40. Dembo, M., B. Goldstein, A. K. Sobotka, and L. M. Lichtenstein. 1979. Degranulation of human basophils: quantitative analysis of histamine release and desensitization due to a bivalent penicilloyl hapten. J. Immunol. 123:1864.
41. Corne, J., R. Djukanovic, L. Thomas, J. Warner, L. Botta, B. Grandordy, D. Gygax, C. Heusser, F. Patalano, W. Richardson et al. 1997. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J. Clin. Invest. 99:879.